HDAC6 and type 2 diabetes mellitus: GLP-1 treatment has been reported to alleviate diabetic retinopathy by inhibiting hyperglycemia-provoked autophagy in the retina of T2D rats mediated through the restoration of GLP-1R expression and HDAC6 inhibition [256].